TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34998000

Group type: EXPERIMENTAL
Intervention: Intralesional MMR injections
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Intralesional BCG injection
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Intralesional candida antigen injection
Number of subjects: 90
Study: 35737193

Group type: EXPERIMENTAL
Intervention: PS + ASD
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 0
Study: 33840228

Group type: EXPERIMENTAL
Intervention: Long-chain omega-3 PUFAs (eicosapentaenoic acid, docosapentaenoic acid, docosahexaenoic acid)
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Long-chain omega-3 PUFAs (top quartile)
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Alpha-linolenic acid
Number of subjects: 203
Study: 35932419

Group type: EXPERIMENTAL
Intervention: Minimum‐residual refractive astigmatism group
Number of subjects: 90

Group type: COMPARATOR
Intervention: Steep‐axis group
Number of subjects: 90
Study: 34580639

Group type: EXPERIMENTAL
Intervention: Finishing and polishing procedures applied to Filtek™ Bulk Fill composite
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Finishing and polishing procedures applied to Dyract XP compomer
Number of subjects: 0
Study: 34033939

Group type: EXPERIMENTAL
Intervention: scaling and root planing with indocyanine green-based antimicrobial photodynamic therapy (perio-green, 0.1 mg/ml)
Number of subjects: 20

Group type: COMPARATOR
Intervention: scaling and root planing (control group)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: scaling and root planing with indocyanine green-based antimicrobial photodynamic therapy
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: microbiome analysis in test sites
Number of subjects: 20
Study: 35928098

Group type: EXPERIMENTAL
Intervention: Diclofenac potassium with hyoscine-N-butyl bromide (HBB)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Diclofenac potassium alone (placebo group)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Both groups (diclofenac potassium with HBB vs placebo)
Number of subjects: 64
Study: 34464752

Group type: EXPERIMENTAL
Intervention: Multimodal prehabilitation combining a mixed-nutrient supplement with structured supervised and home-based exercise training, and relaxation strategies (Prehab)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Standard hospital care (Control)
Number of subjects: 34
Study: 35897381

Group type: EXPERIMENTAL
Intervention: Rotational Atherectomy (RA)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: ShockWave-Intravascular-Lithotripsy (S-IVL)
Number of subjects: 44
Study: 34647106

Group type: EXPERIMENTAL
Intervention: ATTACH™ program (10-week psycho-educational intervention)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 20
Study: 36094967

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 224

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 224
Study: 32338106

Group type: EXPERIMENTAL
Intervention: Low-dose SPN-810 (12/18 mg/day)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Medium-dose SPN-810 (24/36 mg/day)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: High-dose SPN-810 (36/54 mg/day)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study: 33185468

Group type: EXPERIMENTAL
Intervention: 6.25 mg SHP465 mixed amphetamine salts (MAS) once daily
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study: 35606544

Group type: EXPERIMENTAL
Intervention: Laparoscopic lavage
Number of subjects: 88

Group type: COMPARATOR
Intervention: Sigmoidectomy
Number of subjects: 88
Study: 34323334

Group type: EXPERIMENTAL
Intervention: Usual care plus 3 semi-personalised dietary mobile phone text messages per week over a 6 month period
Number of subjects: 130

Group type: COMPARATOR
Intervention: Usual care (in-person dietary counselling)
Number of subjects: 130
Study: 35426742

Group type: EXPERIMENTAL
Intervention: Clinicians responding to empathic opportunities during encounters
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Empathic communication patterns
Number of subjects: 71
Study: 34684055

Group type: EXPERIMENTAL
Intervention: MLD and IPC (compression of 60 to 80 mmHg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: MLD and sham IPC (compression of <30 mmHg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: MLD and IPC (experimental group)
Number of subjects: 30
Study: 32902413

Group type: EXPERIMENTAL
Intervention: Baricitinib (JAK inhibitor)
Number of subjects: 20
Study: 34391573

Group type: EXPERIMENTAL
Intervention: Total thyroidectomy plus prophylactic central compartment lymph node dissection (TTx+pCND)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Total thyroidectomy (TTx)
Number of subjects: 101
Study: 34090814

Group type: EXPERIMENTAL
Intervention: Pharmacists' spiritual care practices
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Private prayer for patients
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Discussion of spiritual/religious topics with patients
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Encouragement for patients to pray
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Referral to clergy or religious leaders
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Praying with patients
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Frequency of spiritual services provided
Number of subjects: 215
Study: 36202719

Group type: EXPERIMENTAL
Intervention: Patient-specific osteosynthesis
Number of subjects: 58

Group type: COMPARATOR
Intervention: Conventional osteosynthesis
Number of subjects: 58
Study: 33517727

Group type: EXPERIMENTAL
Intervention: Capsular sparing (CS) technique (n = 104)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Capsular resection (CR) technique (n = 115)
Number of subjects: 190
Study: 33901247

Group type: EXPERIMENTAL
Intervention: 3-week neck-only rehabilitation programme
Number of subjects: 25
Study: 32142492

Group type: EXPERIMENTAL
Intervention: Hydromorphone 0.05 mg/mL + nalbuphine 0.5 mg/mL (group LN)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Hydromorphone 0.05 mg/mL + nalbuphine 0.7 mg/mL (group MN)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Hydromorphone 0.05 mg/mL + nalbuphine 0.9 mg/mL (group HN)
Number of subjects: 114
Study: 35172888

Group type: EXPERIMENTAL
Intervention: Electrical stimulation (ES) at least 1 hour/day, 4 times a week for 1 year, in addition to usual care.
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Electrical stimulation (ES)
Number of subjects: 100
Study: 33550905

Group type: EXPERIMENTAL
Intervention: MTHFR C677T polymorphism
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: MTHFR A1298C polymorphism
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Linkage disequilibrium analysis
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: MTHFR A1298C genotype prevalence
Number of subjects: 138
Study: 32572017

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 86

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 86
Study: 32385741

Group type: EXPERIMENTAL
Intervention: High-frequency rTMS (20 sessions over 4 weeks)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: High-frequency rTMS
Number of subjects: 31

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 31
Study: 36276997

Group type: EXPERIMENTAL
Intervention: Vaginal delivery (successful)
Number of subjects: 738

Group type: COMPARATOR
Intervention: Vaginal delivery (failed)
Number of subjects: 738
Study: 34095882

Group type: EXPERIMENTAL
Intervention: Cowpea-based feeds (CpF, n=20)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Inulin-based feeds (InF, n=20)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Conventional feeds (ConF, n=18)
Number of subjects: 58
Study: 35621877

Group type: COMPARATOR
Intervention: No anti-HBV regimen (ZDV + intrapartum nevirapine and 1 week of TDF-FTC)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: 3TC regimen (3TC + ZDV + LPV/r)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: FTC-TDF regimen (FTC + TDF + LPV/r)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Maternal HBeAg positive status
Number of subjects: 138
Study: 36250881

Group type: EXPERIMENTAL
Intervention: Minimally invasive plate osteosynthesis (MIPO) technique with long volar plate
Number of subjects: 54
Study: 32988903

Group type: EXPERIMENTAL
Intervention: Afatinib
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Osimertinib
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 102

Group type: COMPARATOR
Intervention: First-generation EGFR TKIs (gefitinib or erlotinib)
Number of subjects: 102
Study: 36274035

Group type: EXPERIMENTAL
Intervention: Dapagliflozin (DAPA)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 34402717

Group type: COMPARATOR
Intervention: Resveratrol supplementation for 30 days
Number of subjects: 0
Study: 35231185

Group type: EXPERIMENTAL
Intervention: GetActive-Fitbit
Number of subjects: 82

Group type: COMPARATOR
Intervention: GetActive
Number of subjects: 82
Study: 32321518

Group type: EXPERIMENTAL
Intervention: Once-daily indacaterol/glycopyrronium (IND/GLY) 110/50 μg
Number of subjects: 3354

Group type: COMPARATOR
Intervention: Twice-daily salmeterol/fluticasone (SFC) 50/500 μg
Number of subjects: 3354

Group type: EXPERIMENTAL
Intervention: Health status measured by SGRQ score
Number of subjects: 3354

Group type: EXPERIMENTAL
Intervention: Health status measured by CAT score
Number of subjects: 3354

Group type: EXPERIMENTAL
Intervention: Dyspnoea assessed via eDiary
Number of subjects: 3354
Study: 36189735

Group type: EXPERIMENTAL
Intervention: Online educational program for breastfeeding
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 33139143

Group type: EXPERIMENTAL
Intervention: Multifaceted stewardship intervention including education on guideline-based treatment, tests of antimicrobial treatment, implementation of a clinical treatment algorithm, and audit and feedback.
Number of subjects: 583

Group type: EXPERIMENTAL
Intervention: Multifaceted stewardship intervention
Number of subjects: 583

Group type: COMPARATOR
Intervention: Control site (no intervention)
Number of subjects: 583
Study: 32717068

Group type: EXPERIMENTAL
Intervention: Oral bisphosphonates (oBP)
Number of subjects: 2565

Group type: COMPARATOR
Intervention: Control (matched non-oBP users)
Number of subjects: 2565
Study: 36114655

Group type: EXPERIMENTAL
Intervention: Serelaxin
Number of subjects: 6128

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6128

Group type: EXPERIMENTAL
Intervention: HFsnEF
Number of subjects: 6128

Group type: EXPERIMENTAL
Intervention: HFrEF
Number of subjects: 6128
Study: 33167078

Group type: COMPARATOR
Intervention: Vitamin A absorption (retinyl palmitate) after soymilk consumption (501 IU vitamin A)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Vitamin D2 absorption after soymilk consumption (119 IU vitamin D2)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Correlation of phospholipids and cholesterol ester concentrations with vitamin A concentration
Number of subjects: 20
Study: 32499247

Group type: EXPERIMENTAL
Intervention: Deep learning using ResNet-50 with regression before classification, 3 input PET slices, and ImageNet pretraining.
Number of subjects: 2582

Group type: EXPERIMENTAL
Intervention: Deep learning using ResNet-50.
Number of subjects: 2582

Group type: COMPARATOR
Intervention: Human performance with 3 readers.
Number of subjects: 2582
Study: 35916440

Group type: EXPERIMENTAL
Intervention: Modified Caregiver Strain Index (MCSI)
Number of subjects: 423

Group type: EXPERIMENTAL
Intervention: Race as a moderating factor
Number of subjects: 423
Study: 35452317

Group type: EXPERIMENTAL
Intervention: Morphine (5 mg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 30
Study: 32728026

Group type: EXPERIMENTAL
Intervention: Non-deceptive placebos
Number of subjects: 0
Study: 35438617

Group type: EXPERIMENTAL
Intervention: Physically active lessons for 2 years
Number of subjects: 34
Study: 34358272

Group type: EXPERIMENTAL
Intervention: Self-hypnosis/self-care
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Music/self-care
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Self-care
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Psychoeducation/CBT
Number of subjects: 203

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 203
Study: 32586394

Group type: EXPERIMENTAL
Intervention: High-Dose LMWH (Enoxaparin 70 IU/kg twice daily)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Low-Dose LMWH (Enoxaparin 4000 IU once daily)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: High-Dose LMWH
Number of subjects: 300

Group type: COMPARATOR
Intervention: Low-Dose LMWH
Number of subjects: 300
Study: 34125289

Group type: EXPERIMENTAL
Intervention: Baerveldt glaucoma implantation
Number of subjects: 50

Group type: COMPARATOR
Intervention: Trabeculectomy (TLE)
Number of subjects: 50
Study: 32037127

Group type: EXPERIMENTAL
Intervention: Amisulpride for 4 weeks (Phase I)
Number of subjects: 446

Group type: EXPERIMENTAL
Intervention: Continuation of amisulpride for 6 additional weeks (Phase II)
Number of subjects: 446

Group type: COMPARATOR
Intervention: Olanzapine for 6 additional weeks (Phase II)
Number of subjects: 446
Study: 35421217

Group type: EXPERIMENTAL
Intervention: Integrated agricultural intervention including distribution of micronutrient powders (MNP), poultry, seeds of greens and onions, soap and chlorine solution, and monthly behavior change trainings.
Number of subjects: 1927

Group type: COMPARATOR
Intervention: Control group (agricultural intervention without additional nutrition-specific and nutrition-sensitive components).
Number of subjects: 1927

Group type: EXPERIMENTAL
Intervention: Integrated agricultural intervention.
Number of subjects: 1927
Study: 33914660

Group type: EXPERIMENTAL
Intervention: ANS + CARN (20 mg/kg body weight)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study: 32729921

Group type: EXPERIMENTAL
Intervention: NCDB analyses using Cox proportional hazards regression models for overall survival
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: NCDB analyses producing P values for survival
Number of subjects: 141
Study: 34578901

Group type: EXPERIMENTAL
Intervention: Comprehensive individualized care by geriatric-experienced care professionals (pathfinders) with nutritional advice, 12-month intervention, up to 7 home visits and 11 phone calls
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Comprehensive individualized care by geriatric-experienced care professionals (pathfinders)
Number of subjects: 244

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 244
Study: 32013882

Group type: EXPERIMENTAL
Intervention: Pb1 (2000 mg/kg Pb (NO3)2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pb2 (10,000 mg/kg Pb (NO3)2)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (CK)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Heterologous expression assays in yeast strain Δycf1
Number of subjects: 0
Study: 35971859

Group type: EXPERIMENTAL
Intervention: Family-based behavioural obesity treatment (FBT)
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Maintenance interventions (8-month duration)
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: FBT and maintenance
Number of subjects: 172
Study: 34649532

Group type: EXPERIMENTAL
Intervention: Peer-assisted learning (PAL)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Lecture-based learning (control group)
Number of subjects: 198
Study: 33571040

Group type: EXPERIMENTAL
Intervention: Sambucus ebulus L.
Number of subjects: 94

Group type: COMPARATOR
Intervention: Hydrocortisone
Number of subjects: 94
Study: 34997178

Group type: EXPERIMENTAL
Intervention: 300 mg/day ALA
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study: 34128813

Group type: EXPERIMENTAL
Intervention: Mobile phone text message reminders
Number of subjects: 434

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 434
Study: 33053078

Group type: EXPERIMENTAL
Intervention: 1.2g of ginger daily for 90 days
Number of subjects: 103

Group type: COMPARATOR
Intervention: 1.2g of placebo daily for 90 days
Number of subjects: 103
Study: 34176309

Group type: EXPERIMENTAL
Intervention: Waterpipe lounge menus with warning message
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Waterpipe lounge menus with nicotine content
Number of subjects: 213

Group type: COMPARATOR
Intervention: Waterpipe lounge menus without warning message
Number of subjects: 213

Group type: COMPARATOR
Intervention: Waterpipe lounge menus without nicotine content
Number of subjects: 213
Study: 33313975

Group type: EXPERIMENTAL
Intervention: PASCAL
Number of subjects: 80

Group type: COMPARATOR
Intervention: MitraClip-XTR
Number of subjects: 80
Study: 34333176

Group type: EXPERIMENTAL
Intervention: Active tPEMF
Number of subjects: 55

Group type: COMPARATOR
Intervention: Sham tPEMF
Number of subjects: 55
Study: 35655860

Group type: EXPERIMENTAL
Intervention: Humanized nursing intervention combined with computed tomography (CT) imaging
Number of subjects: 114

Group type: COMPARATOR
Intervention: Routine nursing intervention
Number of subjects: 114
Study: 34129960

Group type: EXPERIMENTAL
Intervention: Antimalarial drugs (quinine, artemisinin combination therapies, and multiple drug combinations)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Quinine and its derivatives
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Artemisinin combination therapies
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Multiple drug combinations
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Randomized trials evaluating drug safety
Number of subjects: 22
Study: 32541154

Group type: EXPERIMENTAL
Intervention: High urinary KIM-1 indexed for creatinine (uKIM-1/Cr)
Number of subjects: 754

Group type: COMPARATOR
Intervention: Low urinary KIM-1 indexed for creatinine (uKIM-1/Cr)
Number of subjects: 754
Study: 36465660

Group type: COMPARATOR
Intervention: Dim Red Light + Placebo Capsules
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Bright Light Alone
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Bright Light + Exercise + Melatonin
Number of subjects: 36
Study: 33926657

Group type: EXPERIMENTAL
Intervention: Balloon-expandable valves (BEV)
Number of subjects: 447

Group type: COMPARATOR
Intervention: Self-expanding valves (SEV)
Number of subjects: 447

Group type: EXPERIMENTAL
Intervention: General anesthesia (GA)
Number of subjects: 447

Group type: COMPARATOR
Intervention: Local anesthesia with conscious sedation (CS)
Number of subjects: 447
Study: 36103983

Group type: EXPERIMENTAL
Intervention: Renal denervation (RDN)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 0
Study: 33078627

Group type: EXPERIMENTAL
Intervention: 5-minute mindfulness of peace
Number of subjects: 40

Group type: COMPARATOR
Intervention: 5 minutes of active listening
Number of subjects: 40
Study: 34860467

Group type: EXPERIMENTAL
Intervention: Fully covered self‐expanding metal stent (FCSEMS)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Plastic stent (PS)
Number of subjects: 70
Study: 34310730

Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO) treatment
Number of subjects: 70

Group type: COMPARATOR
Intervention: No EPO treatment
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: EPO treatment
Number of subjects: 70
Study: 34015580

Group type: EXPERIMENTAL
Intervention: Intraperitoneal ondansetron
Number of subjects: 50

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 50
Study: 32164535

Group type: EXPERIMENTAL
Intervention: Duodenoscope with disposable cap
Number of subjects: 520

Group type: COMPARATOR
Intervention: Traditional duodenoscope
Number of subjects: 520
Study: 35495419

Group type: EXPERIMENTAL
Intervention: Arachidonic acid (AA) and docosahexaenoic acid (DHA) supplementation
Number of subjects: 207

Group type: COMPARATOR
Intervention: No supplementation (Control)
Number of subjects: 207
Study: 33080122

Group type: EXPERIMENTAL
Intervention: Active tDCS (2.5 mA, anode over C3/cathode over FP2) paired with unloaded cycling for 20 minutes, 10 sessions (5 d/wk for 2 weeks)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Sham tDCS paired with unloaded cycling for 20 minutes, 10 sessions (5 d/wk for 2 weeks)
Number of subjects: 15
Study: 36394750

Group type: EXPERIMENTAL
Intervention: polyethylene glycol loxenatide injection + metformin
Number of subjects: 40

Group type: COMPARATOR
Intervention: metformin
Number of subjects: 40
Study: 36153539

Group type: EXPERIMENTAL
Intervention: Deep-frozen thrombocyte concentrate (DTC)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Room temperature-stored platelets (RSP)
Number of subjects: 158
Study: 34030703

Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Number of subjects: 1218

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction program
Number of subjects: 1218

Group type: COMPARATOR
Intervention: Usual care without any intervention
Number of subjects: 1218
Study: 32329237

Group type: EXPERIMENTAL
Intervention: Brief applied behavior analysis (ABA) intervention
Number of subjects: 36

Group type: COMPARATOR
Intervention: Evaluation and monitoring-only group (Control)
Number of subjects: 36
Study: 36203053

Group type: EXPERIMENTAL
Intervention: Running HIIT
Number of subjects: 11

Group type: COMPARATOR
Intervention: Cycling HIIT
Number of subjects: 11
Study: 33230268

Group type: EXPERIMENTAL
Intervention: sertraline
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: venlafaxine-XR
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: escitalopram
Number of subjects: 128

Group type: COMPARATOR
Intervention: healthy controls
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: NAc-ventral ACC
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: NAc-thalamus
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: NAc-paracingulate gyrus
Number of subjects: 128
Study: 32950893

Group type: EXPERIMENTAL
Intervention: RELAXaHEAD app with progressive muscle relaxation (PMR)
Number of subjects: 62

Group type: COMPARATOR
Intervention: RELAXaHEAD app without PMR (monitored usual care)
Number of subjects: 62
Study: 34175572

Group type: EXPERIMENTAL
Intervention: Treatment group (provided balanced information about ethical dilemmas)
Number of subjects: 700

Group type: COMPARATOR
Intervention: Control group (not provided balanced information)
Number of subjects: 700